{
    "2021-10-25": [
        [
            {
                "time": "2021-10-07",
                "original_text": "Will Pfizer ETFs Gain on Positive COVID-19 Booster Dose Data?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "ETFs",
                        "Positive",
                        "COVID-19",
                        "Booster",
                        "Dose"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-07",
                "original_text": "Pfizer CEO says company will produce 4 billion COVID-19 doses in 2022",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "CEO",
                        "produce",
                        "4 billion",
                        "COVID-19",
                        "doses",
                        "2022"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-07",
                "original_text": "Pfizer CEO: We will 'immediately' distribute vaccine to kids once we have FDA approval",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "CEO",
                        "distribute",
                        "vaccine",
                        "kids",
                        "FDA",
                        "approval"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-07",
                "original_text": "Moderna Data Shows Covid-19 Vaccine Produced Strong Immune Response in 6- to 11-Year-Olds",
                "features": {
                    "keywords": [
                        "Moderna",
                        "Covid-19",
                        "Vaccine",
                        "Strong",
                        "Immune",
                        "Response",
                        "6-",
                        "11-Year-Olds"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-07",
                "original_text": "Fauci says U.S. is on track to start vaccinating kids aged 5 to 11 by November, as FDA advisers prepare to meet on the matter",
                "features": {
                    "keywords": [
                        "Fauci",
                        "U.S.",
                        "vaccinating",
                        "kids",
                        "aged",
                        "5",
                        "11",
                        "November",
                        "FDA",
                        "advisers"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-07",
                "original_text": "Moderna Rises on Report Its Covid Shot Shows Promise in Children 6-11",
                "features": {
                    "keywords": [
                        "Moderna",
                        "Rises",
                        "Report",
                        "Covid",
                        "Shot",
                        "Promise",
                        "Children",
                        "6-11"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-07",
                "original_text": "FDA committee to discuss BioNTech/Pfizer's COVID-19 shot in children 5 to 11",
                "features": {
                    "keywords": [
                        "FDA",
                        "committee",
                        "discuss",
                        "BioNTech",
                        "Pfizer",
                        "COVID-19",
                        "shot",
                        "children",
                        "5",
                        "11"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}